Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Atopic Dermatitis Drugs Market 2017 Trends, Growth and Forecast to 2021

Monday, February 27, 2017 3:19
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Atopic dermatitis is a common, chronic, relapsing, inflammatory disease that primarily affects young children. Atopy refers to an inherited tendency to produce IgE antibodies, whereas, dermatitis means inflammation of the skin. Atopic dermatitis is associated with asthma, inhalant allergies (hay fever), and chronic dermatitis. In this condition, the skin becomes extremely itchy and inflamed, which causes redness, cracking, weeping, swelling, vesicle formation, crushing, and scaling. Atopic dermatitis is very common worldwide, and its prevalence rate is increasing. The data estimates suggest that nearly 60% of the patients develop symptoms in the first year of life, and 88%-92% develop symptoms before the age of five.

Publisher’s analysts forecast the global atopic dermatitis drugs market to grow at a CAGR of 4.20% during the period 2017-2021.

For more information about this report: http://www.reportsweb.com/global-atopic-dermatitis-drugs-market-2017-2021 .                

Covered in this report 
The report covers the present scenario and the growth prospects of the global atopic dermatitis drugs market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of atopic dermatitis drugs.

The market is divided into the following segments based on geography: 
- Americas
- APAC
- EMEA

Publisher’s report, Global Atopic Dermatitis Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- LEO Pharma
- Mylan
- Valeant
- Bayer HealthCare
- Encore Dermatology 

 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001608750/sample .                       

 

Market driver 
- Growing prevalence of food allergies exacerbating atopic dermatitis
- For a full, detailed list, view our report 

Market challenge 
- Poor patient adherence due to inadequate information on drug usage
- For a full, detailed list, view our report 

Market trend 
- Increasing M&A leading to market consolidation
- For a full, detailed list, view our report 

Inquire for Report at http://www.reportsweb.com/inquiry&RW0001608750/buying .                       

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.